Journal ArticleDOI
Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism
Reads0
Chats0
TLDR
The results demonstrate the saturable transfer of L‐KYN across the blood–brain barrier and suggest that circulating L‐ KYN, 3‐HKYN, and ANA may each contribute significantly to respective cerebral pools under normal conditions.Abstract:
To evaluate the potential contribution of circulating kynurenines to brain kynurenine pools, the rates of cerebral uptake and mechanisms of blood-brain barrier transport were determined for several kynurenine metabolites of tryptophan, including L-kynurenine (L-KYN), 3-hydroxykynurenine (3-HKYN), 3-hydroxyanthranilic acid (3-HANA), anthranilic acid (ANA), kynurenic acid (KYNA), and quinolinic acid (QUIN), in pentobarbital-anesthetized rats using an in situ brain perfusion technique. L-KYN was found to be taken up into brain at a significant rate [permeability-surface area product (PA) = 2-3 x 10(-3) ml/s/g] by the large neutral amino acid carrier (L-system) of the blood-brain barrier. Best-fit estimates of the Vmax and Km of saturable L-KYN transfer equalled 4.5 x 10(-4) mumol/s/g and 0.16 mumol/ml, respectively. The same carrier may also mediate the brain uptake of 3-HKYN as D,L-3-HKYN competitively inhibited the brain transfer of the large neutral amino acid L-leucine. For the other metabolites, uptake appeared mediated by passive diffusion. This occurred at a significant rate for ANA (PA, 0.7-1.6 x 10(-3) ml/s/g), and at far lower rates (PA, 2-7 x 10(-5) ml/s/g) for 3-HANA, KYNA, and QUIN. Transfer for KYNA, 3-HANA, and ANA also appeared to be limited by plasma protein binding. The results demonstrate the saturable transfer of L-KYN across the blood-brain barrier and suggest that circulating L-KYN, 3-HKYN, and ANA may each contribute significantly to respective cerebral pools. In contrast, QUIN, KYNA, and 3-HANA cross the blood-brain barrier poorly, and therefore are not expected to contribute significantly to brain pools under normal conditions.read more
Citations
More filters
Journal ArticleDOI
Induction of the kynurenine pathway by neurotropic influenza A virus infection.
TL;DR: The present results indicate that central nervous system infections during early life can activate the entire kynurenine pathway and is likely to result in the generation of several bioactive metabolites, as supported by the finding of a transient increase of kynurenic acid.
Anthranilic Acid: A Potential Biomarker and Treatment Target for Schizophrenia.
TL;DR: Assessment of the third immediate downstream Kyn metabolite, anthranilic acid (AA), found 2-fold increase of AA and 3-fold decrease of 3-HK concentrations in serum of schizophrenia patients, warranting further studies of AA as biological marker in, at least, a subgroup (associated with autoimmune mechanisms) of schizophrenia Patients and as a new target for therapeutic intervention.
Journal ArticleDOI
Microbiota modulation as preventative and therapeutic approach in Alzheimer's disease.
Laura Bonfili,Valentina Cecarini,Olee Gogoi,Chunmei Gong,Massimiliano Cuccioloni,Mauro Angeletti,Giacomo Rossi,Anna Maria Eleuteri +7 more
TL;DR: The role of gut microbiota in AD is dissected and recent advances in the development of new multitarget strategies for microbiota modulation to be used as possible preventative and therapeutic approaches in AD are highlighted.
Journal ArticleDOI
Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease.
Pratishtha Chatterjee,Pratishtha Chatterjee,Henrik Zetterberg,Kathryn Goozee,Chai K. Lim,Kelly R. Jacobs,Nicholas J. Ashton,Abdul Hye,Abdul Hye,Steve Pedrini,Hamid R. Sohrabi,Tejal M. Shah,Tejal M. Shah,Prita R. Asih,Preeti Dave,Kaikai Shen,Kevin Taddei,David B. Lovejoy,Gilles J. Guillemin,Kaj Blennow,Kaj Blennow,Ralph N. Martins +21 more
TL;DR: The current study suggests that an association between neurodegeneration and neuroinflammation manifests in the periphery, suggesting that preventing cytoskeleton cytotoxicity by KP metabolites may have therapeutic potential.
Journal ArticleDOI
Kynurenine emerges from the shadows - Current knowledge on its fate and function.
Marta Marszalek-Grabska,Katarzyna Walczak,Kinga Gawel,Katarzyna Wicha-Komsta,Sylwia Wnorowska,Artur Wnorowski,Waldemar A. Turski +6 more
TL;DR: A review of the current knowledge of kynurenine fate and function can be found in this article, where the authors emphasize its importance for vital physiological and pathological processes, including inflammation and carcinogenesis.
References
More filters
Journal ArticleDOI
Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain
TL;DR: Intracerebral injection of the neuroexcitatory tryptophan metabolite, quinolinic acid, has behavioral, neurochemical and neuropathological consequences reminiscent of those of exogenous excitotoxins, such as kainic and ibotenic acids.
Journal ArticleDOI
Distinct mediating systems for the transport of neutral amino acids by the ehrlich cell
Journal ArticleDOI
Amino acid assignment to one of three blood-brain barrier amino acid carriers
William H. Oldendorf,John Szabo +1 more
TL;DR: Affinity for a basic amino acid carrier system was demonstrated for arginine, ornithine, and lysine and a third, low-capacity independent carrier system transporting aspartic and glutamic acids was demonstrated.
Journal ArticleDOI
An in situ brain perfusion technique to study cerebrovascular transport in the rat
TL;DR: The in situ brain perfusion technique is a sensitive new method to study cerebrovascular transfer in the rat and permits absolute control of perfusate composition.